Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
Shanghai ninth people's hospital, Shanghai, China
San Raffaele Hospital, Milan, Milano, Italy
University Medical Centre Ljubljana, Ljubljana, Slovenia
Konkuk University Medical Center, Seoul, Korea, Republic of
Hôpital Roger Salengro, CHU, Lille, France
American University of Beirut, Beirut, Lebanon
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
Kasr El Aini Hospital, Cairo, Egypt
Service d'Anesthésie, Hôpital Foch, Suresnes, Ile De France, France
Service d'Anesthésie du Centre Clinical, Soyaux, Poitou-Charentes, France
Service d'Anesthésie Réanimation Chirurgicale, CHU Besançon, Besançon, Bourgogne-Franche-Comté, France
OrthoCarolina Research Institute, Charlotte, North Carolina, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.